Macrohard Institute of Health

The Macrohard Institute of Health (MIH) is a United States-based non-profit research organization dedicated to advancing clinical and pharmaceutical research to improve patient outcomes. The institute specializes in conducting rigorous basic and clinical studies, with a particular focus on the intersection of Western medicine and traditional Chinese medicine (TCM). MIH's research portfolio encompasses a wide range of therapeutic areas, including autoimmune diseases such as rheumatoid arthritis and Sjögren's syndrome, cardiovascular health, and infectious diseases like COVID-19. The organization is known for its contributions to medical literature through meta-analyses and clinical trials, often collaborating with international academic institutions to address significant unmet medical needs.